Precision BioSciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -126.2% | – | – | – | – | – | – | – | – | |
| – | +124.2% | +64.0% | +125.9% | +84.6% | +3.9% | -11.7% | -8.3% | -44.6% | -39.9% | |
| – | – | +485.4% | +264.5% | +54.2% | +19.8% | +16.2% | -26.9% | -10.2% | -19.2% | |
| – | +250.9% | +316.0% | +666.2% | -26.9% | -172.9% | – | – | – | – | |
| – | -105.1% | – | – | – | – | +23.1% | -272.1% | – | – | |
| – | +168.2% | +181.7% | +57.3% | -79.6% | +15.3% | -42.8% | -31.4% | -89.0% | -66.0% | |
| – | +165.8% | +184.0% | +57.5% | -79.6% | +15.3% | -42.8% | – | -103.7% | +194.9% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -2,042.9% | -100.0% | – | -99.5% | +9,662.0% | +11.1% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -93.8% | -101.9% | – | -100.0% | – | -100.0% | |
| – | -92.4% | – | +63.3% | -99.2% | +5,206.3% | +34.7% | -94.3% | +836.5% | +88.6% | |
| – | -139.3% | – | +92.4% | -217.2% | – | -14.8% | -258.8% | – | – | |
| – | -133.0% | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.